Menu
Menu
•
PLEASANTON, Calif.‐‐(BUSINESS WIRE)‐‐Irisvision co-founder and CEO Ammad Khan today introduced a new company, RadiusXR, to coincide with the opening of the American Academy of Ophthalmology (AAO) 2022 meeting in Chicago. RadiusXR builds on the therapeutic legacy of IrisVision by introducing diagnostic capability to the proprietary VR/AR assistive device.
After the CES Award-winning 2017 launch of IrisVision, which has helped thousands of legally blind individuals see again, the company sought to leverage its core technology to benefit the eyecare industry by creating a patient-guided exam process that makes it easier and more affordable to diagnose a range of vision problems that are pervasive in the U.S. More than 32 million Americans aged 18+ are affected by vision loss, according to the IPUMS National Health Interview Survey¹.
Using a single RadiusXR headset, patients can self-perform a range of vision tests that are clinically equivalent to gold standard exams. The exams currently performed with the RadiusXR testing platform are Visual Field, Visual Acuity, Contrast Sensitivity, Amsler Grid, and Color Scheme. Development is ongoing.
The shift to patient-guided testing enhances eyecare practice workflow and enables a single technician to administer several test sessions concurrently, doubling patient capacity.
The fashion-forward design of RadiusXR is a significant leap forward in wearable devices, with the look and feel of a pair of fashionable sunglasses. RadiusXR is the industry’s lightest wearable device, weighing just under 6 oz., and features all-day battery life.
The small, lightweight design overcomes the challenges of expensive and bulky legacy devices that force patients to sit in uncomfortable positions for testing. Exams can be conducted beyond exam lanes, allowing a patient’s exam in nontraditional spaces like waiting rooms, remote offices, and lobbies. With RadiusXR, opportunities for greater accessibility and care are boundless.
A breakthrough feature of the RadiusXR platform is the immersive educational media library that can be tailored to each patient. This content is configured by each practice to display at an appropriate time during the exam experience automatically, eliminating the repetitive, time-consuming task of providing patients with educational information about their vision challenges while ensuring relevant information is consistently presented.
The platform includes a Business Suite of management tools that streamline patient check-in, enable staff to customize the experience for multiple patients, and make it easier for eyecare professionals to manage business aspects critical to their practice’s ongoing success.
The launch of RadiusXR is guided by John Trefethen, who joins the company as Chief Marketing Officer. Trefethen previously served in leadership roles at several medical device companies, including industry giants Zeiss Medical Technology and Topcon Healthcare.
“Early diagnosis is the key to treating many conditions that can lead to vision loss,” said Trefethen. “We believe a testing platform that combines a comfortable size with an engaging, immersive experience makes patients more likely to seek testing — and to be re-tested more frequently. Diagnosing conditions earlier and regularly tracking disease progression gives eyecare professionals an immense advantage in caring for their patients’ vision.
For the more than 30 million Americans with vision defects that negatively impact their lives, the potential of RadiusXR is genuinely life-changing.”
The RadiusXR platform is a revolutionary portable vision diagnostic and patient engagement system. It combines medical-grade diagnostics, business management tools, and patient education resources within a wearable spatial computing device. The RadiusExam® and proprietary algorithms provide diagnostic testing results equivalent to current gold standards demonstrated through a clinical trial that shows statistical noninferiority of estimated sensitivities compared to SITA-Standard. This comprehensive hardware and software system empowers medical professionals to diagnose patients accurately, enhance patient engagement, and reduce staff workload. It enables patients to perform self-guided vision exams with minimal supervision, thereby aiding in the growth, flow and efficiency of eye care practices.
Mon – Fri 5 am – 5 pm PST
